5174EGP
- Active ingredient
- denosumab
- Strength
- 60 mg
- Form
- syringe
- Manufacturer
- amgen > multipharma
- Route
- injection
Uses
Used for osteoporosis in patients at high fracture risk and for increasing bone mass in selected cancer-related and glucocorticoid-induced conditions.
Do not use if
Pre-existing hypocalcemia, pregnancy, and hypersensitivity to denosumab or formulation components.
Side effects
May cause hypocalcemia, musculoskeletal pain, hypersensitivity reactions, osteonecrosis of the jaw, and atypical femoral fractures.
Warnings
Advanced kidney disease increases the risk of severe hypocalcemia. Monitor calcium levels and oral health.
How it works
Monoclonal antibody that binds RANKL and inhibits osteoclast formation, function, and survival.
Storage
Store refrigerated at 2–8°C in the original carton. Do not freeze.
